High prevalence of fatigue in inflammatory bowel disease: A case control study

Journal of Crohn's and Colitis

Volumn 5, Issue 4, 2011, Pages 332-337

  Römkens, Tessa E H ^a   van Vugt van Pinxteren, Maria W J ^a   Nagengast, Fokko M ^a   van Oijen, Martijn G H ^a,b   de Jong, Dirk J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Crohn's disease; Fatigue; IBD; Piper fatigue scale; Ulcerative colitis

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; STEROID;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROHN DISEASE; DISEASE SEVERITY; FATIGUE; FEMALE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PIPER FATIGUE SCALE; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; ULCERATIVE COLITIS;

ADULT; CASE-CONTROL STUDIES; COMORBIDITY; FATIGUE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PREVALENCE; SELF REPORT;

EID: 79958830132     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.02.008     Document Type: Article

References (32)

1. Danese S., Fiocchi C. Etiopathogenesis of inflammatory bowel diseases. World J Gastroenterol 2006, 12:4807-4812.
2. Minderhoud I.M., Oldenburg B., van Dam P.S., van Berge Henegouwen G.P., et al. High prevalence of fatigue in quiescent inflammatory bowel disease is not related to adrenocortical insufficiency. Am J Gastroenterol 2003, 98:1088-1093.
3. Hamilton J., Butler L., Wagenaar H., Sveinson T., Ward K.A., McLean L., et al. The impact and management of cancer-related fatigue on patients and families. Can Oncol Nurs J 2001, 11:192-198.
4. Piper B.F., Lindsey A.M., Dodd M.J. Fatigue mechanisms in cancer patients: developing nursing theory. Oncol Nurs Forum 1987, 14:17-23.
5. Dagnelie P.C., Pijls-Johannesma M.C., Pijpe A., Boumans B.J., Skrabanja A.T., Lambin P., et al. Psychometric properties of the revised Piper Fatigue Scale in Dutch cancer patients were satisfactory. J Clin Epidemiol 2006, 59:642-649.
6. Van Hoogmoed D., Fransen J., Bleijenberg G., Van Riel P. Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis. Rheumatology (Oxford) 2010, 49(7):1294-1302. jul.
7. Smets E.M., Garssen B., Bonke B., De Haes J.C. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995, 39:315-325.
8. Marcus S.B., Strople J.A., Neighbors K., Weissberg-Benchell J., Nelson S.P., Limbers C., et al. Fatigue and health-related quality of life in pediatric inflammatory bowel disease. Clin Gastroenterol Hepatol 2009, 7:554-561.
9. Jones D.E., Gray J.C., Newton J. Perceived fatigue is comparable between different disease groups. QJM 2009, 102(9):617-624. Sep.
10. Naess H., Sundal E., Myhr K.M., Nyland H.I. Postinfectious and chronic fatigue syndromes: clinical experience from a tertiary-referral centre in Norway. In Vivo 2010, 24:185-188.
11. Satsangi J., Silverberg M.S., Vermeire S., Colombel J.F. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006, 55:749-753.
12. Harvey R.F., Bradshaw M.J. Measuring Crohn's disease activity. Lancet 1980, 1:1134-1135.
13. Wiese D., Lashner B., Seidner D. Measurement of nutrition status in Crohn's disease patients receiving infliximab therapy. Nutr Clin Pract 2008, 23:551-556.
14. Ruemmele F.M., Lachaux A., Cézard J.P., Morali A., Maurage C., Giniès J.L., et al. Efficacy of infliximab in pediatric Crohn's disease: a randomized multicenter open-label trial comparing scheduled to on demand maintenance therapy. Inflamm Bowel Dis 2009, 15:388-394.
15. Piper B.F., Dibble S.L., Dodd M.J., Weiss M.C., Slaughter R.E., Paul S.M., et al. The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 1998, 25:677-684.
16. Griffiths A.M., Nicholas D., Smith C., Munk M., Stephens D., Durno C., et al. Development of a quality-of-life index for pediatric inflammatory bowel disease: dealing with differences related to age and IBD type. J Pediatr Gastroenterol Nutr 1999, 28:S46-S52.
17. Vermeire S., Van A.G., Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys?. Gut 2006, 55:426-431.
18. Brown D.J., McMillan D.C., Milroy R. The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer 2005, 103:377-382.
19. Scott H.R., McMillan D.C., Forrest L.M., Brown D.J., McArdle C.S., Milroy R., et al. The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer 2002, 87:264-267.
20. Scott H.R., McMillan D.C., Brown D.J., Forrest L.M., McArdle C.S., Milroy R., et al. A prospective study of the impact of weight loss and the systemic inflammatory response on quality of life in patients with inoperable non-small cell lung cancer. Lung Cancer 2003, 40:295-299.
21. Shafqat A., Einhorn L.H., Hanna N., Sledge G.W., Hanna A., Juliar B.E., et al. Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment. Ann Oncol 2005, 16:1545-1550.
22. Gomollon F., Gisbert J.P. Anemia and inflammatory bowel diseases. World J Gastroenterol 2009, 15:4659-4665.
23. Lind M., Vernon C., Cruickshank D., Wilkinson P., Littlewood T., Stuart N., et al. The level of haemoglobin in anaemic cancer patients correlates positively with quality of life. Br J Cancer 2002, 86:1243-1249.
24. Ondersma S.J., Lumley M.A., Corlis M.E., Tojek T.M., Tolia V. Adolescents with inflammatory bowel disease: the roles of negative affectivity and hostility in subjective versus objective health. J Pediatr Psychol 1997, 22:723-738.
25. Suurmeijer T.P., Waltz M., Moum T., Guillemin F., van Sonderen F.L., Briançon S., et al. Quality of life profiles in the first years of rheumatoid arthritis: results from the EURIDISS longitudinal study. Arthritis Rheum 2001, 45:111-121.
26. Gielissen M.F., Verhagen C.A., Bleijenberg G. Cognitive behaviour therapy for fatigued cancer survivors: long-term follow-up. Br J Cancer 2007, 97:612-618.
27. Gielissen M.F., Verhagen S., Witjes F., Bleijenberg G. Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: a randomized controlled trial. J Clin Oncol 2006, 24:4882-4887.
28. Knoop H., Bleijenberg G., Gielissen M.F., van der Meer J.W., White P.D. Is a full recovery possible after cognitive behavioural therapy for chronic fatigue syndrome?. Psychother Psychosom 2007, 76:171-176.
29. Evers A.W., Kraaimaat F.W., van Riel P.L., et al. Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial. Pain 2002, 100:141-153.
30. Szigethy E., Kenney E., Carpenter J., et al. Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression. J Am Acad Child Adolesc Psychiatry 2007, 46:1290-1298.
31. Mahmud N., Stinson J., O'Connell M.A., et al. Microalbuminuria in inflammatory bowel disease. Gut 1994, 35:1599-1604.
32. Mahmud N., O'Toole D., O'Hare N., et al. Evaluation of renal function following treatment with 5-aminosalicylic acid derivatives in patients with ulcerative colitis. Aliment Pharmacol Ther 2002, 16:207-215.